Biosenta Inc.
ZRO
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 63.06% | 63.50% | 64.81% | 65.11% | -1,449.37% |
| Total Depreciation and Amortization | 5.88% | 58.33% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -69.54% | -72.28% | -72.59% | -76.76% | 420.58% |
| Change in Net Operating Assets | -8.67% | -14.95% | -59.21% | -65.48% | -24.82% |
| Cash from Operations | 52.55% | 36.16% | 15.79% | -40.29% | -52.58% |
| Capital Expenditure | -59.48% | -59.48% | -59.48% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -59.48% | -59.48% | -59.48% | -- | -- |
| Total Debt Issued | 227.13% | -27.72% | -34.13% | -100.00% | -77.19% |
| Total Debt Repaid | 115.56% | -- | -- | -- | -60,100.00% |
| Issuance of Common Stock | -- | -51.98% | 21.12% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.08% | 5,204.26% | 266.47% | -- | -- |
| Cash from Financing | -49.18% | -36.00% | -38.18% | 42.12% | 61.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.09% | -257.45% | -182.14% | 106.96% | 33.59% |